Image | Product Name | API Name | Last Drug Patent Expires | Details | Year of start producing |
---|---|---|---|---|---|
![]() | Cas No. 3680-69-1, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | Ruxolitinib, Tofacitinib, Ritlecitinib, Baricitinib, Abrocitinib, Delgocitinib | 5/5/2041 (Ruxolitinib); 3/14/2034 (Tofacitinib); 12/3/2034 (Ritlecitinib); 11/30/2032 (Baricitinib); 2/19/2034 (Abrocitinib) | View detail » | 2016 |
![]() | CAS No. 1146629-83-5, (R)-3-(4-broMo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | Ruxolitinib | 5/5/2041 (Ruxolitinib) | View detail » | 2022 |
![]() | Cas No. 591769-05-0, 3-Cyclopentylacrylonitrile | Ruxolitinib | 5/5/2041 (Ruxolitinib) | View detail » | 2016 |
![]() | Cas No. 941685-27-4, 4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine | Ruxolitinib, Baricitinib | 5/5/2041 (Ruxolitinib); 11/30/2032 (Baricitinib) | View detail » | 2017 |